Director, Toxicology
Apellis Pharmaceuticals, Inc. | |
life insurance, flex time, 401(k) | |
United States, Massachusetts, Waltham | |
100 5th Avenue (Show on map) | |
Dec 03, 2024 | |
Position Summary: The Director (Head) of Toxicology will lead Apellis' toxicology efforts in characterizing and derisking new drug candidates to move into and through clinical development. The position will play a critical role in leading and building the Apellis toxicology organization; driving the toxicology strategy to advance our growing pipeline of product candidates. In this role, the primary responsibilities will include strategy, planning, design/conduct and oversight of the investigative non-GLP and GLP compliant in vitro, small and large animal toxicology studies. These studies will support a broad range of activities across research, preclinical and development stages of the pipeline and across multiple therapeutic programs. The incumbent will be expected to explore novel technologies to characterize and derisk compounds of interest. In collaboration with other NCD colleagues (operations, DMPK, BA), will coordinate interactions with CRO's to ensure delivery of study results and reports consistent with program timeline. Additionally, the candidate will be accountable for the delivery of high-quality documents for regulatory filings (briefing books, IND/CTA, IB, NDA). He or she will be an integral part of a dynamic discovery and development team at Apellis and will be expected to work closely in cross-functional teams. Key Responsibilities Include:
Education, Registration & Certification:
Experience:
Skills, Knowledge & Abilities:
Benefits and Perks: Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more! Visithttps://apellis.com/careers/ to learn more. Company Background: Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visithttp://apellis.comor follow us onTwitterandLinkedIn EEO Statement: Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law. For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records. Other Duties: Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice. #LI-CL1 |